We predicted three drug efflux pumps of the ATP binding cassette subfamily (namely MRP2, MRP3, and MRP5) as potential molecular targets of DIPH, which are already associated with platinum resistance in ovarian cancer (Surowiak et al., 2006). This evidence concerns the gene ABCC2 and ovarian cancer.